Bovine respiratory disease: commercial vaccines currently available in Canada.
about
Quantitative trait loci associated with the immune response to a bovine respiratory syncytial virus vaccineGenome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolatesA three-way comparative genomic analysis of Mannheimia haemolytica isolates.Experimental infectious respiratory disease in groups of calves: lobar distribution, variance, and sample-size requirements for vaccine evaluationMannheimia (Pasteurella) haemolytica leukotoxin binding domain lies within amino acids 1 to 291 of bovine CD18.Bovine CD18 is necessary and sufficient to mediate Mannheimia (Pasteurella) haemolytica leukotoxin-induced cytolysisA mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves.Monomeric expression of bovine beta2-integrin subunits reveals their role in Mannheimia haemolytica leukotoxin-induced biological effects.Infection of cultured bovine cells with bovine herpesvirus 1 (BHV-1) or Sendai virus induces different beta interferon subtypesHerpes simplex virus type 1 and bovine herpesvirus 1 latency.A protein encoded by the bovine herpesvirus 1 latency-related gene interacts with specific cellular regulatory proteins, including CCAAT enhancer binding protein alpha.Mammalian alphaherpesvirus miRNAs.Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.Seroprevalence of respiratory viral pathogens of indigenous calves in Western Kenya.Intact signal peptide of CD18, the beta-subunit of beta2-integrins, renders ruminants susceptible to Mannheimia haemolytica leukotoxin.Identification of a novel bovine herpesvirus 1 transcript containing a small open reading frame that is expressed in trigeminal ganglia of latently infected cattle.Regulation of Innate Immune Responses by Bovine Herpesvirus 1 and Infected Cell Protein 0 (bICP0).Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.Sequence diversity and molecular evolution of the heat-modifiable outer membrane protein gene (ompA) of Mannheimia(Pasteurella) haemolytica, Mannheimia glucosida, and Pasteurella trehalosi.Outer membrane protein A of bovine and ovine isolates of Mannheimia haemolytica is surface exposed and contains host species-specific epitopesA mutation in the latency-related gene of bovine herpesvirus 1 inhibits protein expression from open reading frame 2 and an adjacent reading frame during productive infection.Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.Genes controlling vaccine responses and disease resistance to respiratory viral pathogens in cattle.Another 2-way MLV vaccine against agents of bovine respiratory disease.Serum IgG response in calves to the putative pneumonic virulence factor Gs60 of Mannheimia haemolytica A1.
P2860
Q28731287-7B07308D-64A0-4E4E-B8C8-D2A2D0B3651CQ33617018-A497949C-EC75-4B98-A8E9-E3724E025582Q33710187-DE3327B6-80F3-435B-BE68-FAF58DF176E9Q33840614-B759792F-E9F5-47CD-B677-4B8AA212FB48Q34033814-BECECA1E-EFA7-47A7-96ED-4C1371D38DC1Q34129944-F4838068-9875-427C-BCCC-410E63B39F4AQ34341150-3E6579B4-2382-4FC8-91A6-14F2F1B3B464Q34663124-5E4DA488-7410-4DA7-8A5C-C9EAD351AE71Q34807495-3D1F74FB-21FD-42C5-845F-01B4138069D2Q35044114-B5863576-D5CE-4CEB-8F8A-EA5C59AB2233Q35634409-6BD31875-4652-45D1-8E33-89DF80421A65Q36057726-73A79280-9EED-4666-B92A-74DA4AB175B6Q36110827-6F025507-3FC2-4168-8D77-38B00069CCBCQ37292405-34D8CCF3-30EE-4B15-93CD-5D12ECA4BB06Q37340872-5DCEF27B-DA3F-4F63-90B7-8822C05455F1Q37730671-AC7648F6-9F40-4EA1-82D9-88BC3B9ACAD5Q38613277-848B7323-E731-405A-A9FA-8A365D0FD83CQ38847190-8195C275-838F-4CF2-8049-3BB41619F574Q40000677-CF7BAAC9-BF65-47CD-8DCA-2E683436D33EQ40387690-24C4BD69-536F-4F77-9B58-8EBCAC6754AEQ40584510-73728863-A040-4FD1-939A-DAC021242448Q42132132-471C3DD7-6323-494C-BA4D-EA3B2415E7EDQ42265533-42DF0871-571B-4D26-B532-C21FFD0C9C98Q42413641-F2EF7325-D67A-44A8-A35D-361C3AA08D29Q42562780-9073440E-833E-4DFF-9F56-AEDA3851EC69
P2860
Bovine respiratory disease: commercial vaccines currently available in Canada.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Bovine respiratory disease: commercial vaccines currently available in Canada.
@ast
Bovine respiratory disease: commercial vaccines currently available in Canada.
@en
type
label
Bovine respiratory disease: commercial vaccines currently available in Canada.
@ast
Bovine respiratory disease: commercial vaccines currently available in Canada.
@en
prefLabel
Bovine respiratory disease: commercial vaccines currently available in Canada.
@ast
Bovine respiratory disease: commercial vaccines currently available in Canada.
@en
P2860
P1476
Bovine respiratory disease: commercial vaccines currently available in Canada
@en
P2093
P E Shewen
S L Bowland
P2860
P577
2000-01-01T00:00:00Z